Oropharyngeal cancer patients report benefit in salivary function with reduction of radiation dose to bilateral IB lymph nodes
For head and neck cancer patients undergoing radiation therapy, a reduction in the amount of radiation treatment volume to the submandibular (level IB) lymph nodes resulted in better patient-reported salivary function, according to research. The study results also found significant reductions in radiation dose to the salivary organs, and good local regional control. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 20, 2014 Category: Science Source Type: news
Patients with oropharyngeal cancer report quality of voice, speech affected post-treatment
Oropharyngeal cancer patients treated with combined chemotherapy and radiation therapy reported a decrease in their voice and speech quality (VSQ) for up to one year after the completion of treatment, according to research. The study further shows that limiting the dose of radiation to the glottic larynx (GL) to less than 20 Gy resulted in a decrease in post-treatment VSQ problems, and that patient-reported VSQ indicated more adverse effects from treatment compared to independent physician assessment. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 20, 2014 Category: Science Source Type: news
HPV-positive squamous cell carcinoma of the oropharynx patients' recurrence differs from HPV-negative patients
Patients with HPV-positive squamous cell carcinoma of the oropharynx (SCCOP) had a longer time to development of distant metastasis (DM) after initial treatment, and had more metastatic sites in more atypical locations compared to HPV-negative patients. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 20, 2014 Category: Science Source Type: news
HPV-positive oropharyngeal cancer patients nearly twice as likely to survive as HPV-negative patients
A retrospective analysis of oropharyngeal patients with recurrence of disease after primary therapy found that HPV-positive patients had a higher overall survival rate than HPV-negative patients (at two years post-treatment, 54.6 percent vs. 27.6 percent, respectively), according to research. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 20, 2014 Category: Science Source Type: news
Patients with oropharyngeal cancer report quality of voice and speech affected post-treatment
(American Society for Radiation Oncology) Oropharyngeal cancer patients treated with combined chemotherapy and radiation therapy reported a decrease in their voice and speech quality for up to one year after the completion of treatment, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 20, 2014 Category: Cancer & Oncology Source Type: news
HPV-positive SCCOP patients' recurrence differs from HPV-negative patients
(American Society for Radiation Oncology) Patients with HPV-positive squamous cell carcinoma of the oropharynx had a longer time to development of distant metastasis after initial treatment, and had more metastatic sites in more atypical locations compared to HPV-negative patients, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 20, 2014 Category: Cancer & Oncology Source Type: news
HPV-positive OPSCC patients nearly twice as likely to survive as HPV-negative patients
(American Society for Radiation Oncology) A retrospective analysis of oropharyngeal patients with recurrence of disease after primary therapy in the Radiation Therapy Oncology Group studies 0129 or 0522 found that HPV-positive patients had a higher overall survival rate than HPV-negative patients (at two years post-treatment, 54.6 percent versus 27.6 percent, respectively), according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 20, 2014 Category: Cancer & Oncology Source Type: news
OncoBriefs: H&N Cancer, Melanoma, Disparities
(MedPage Today) -- Drinking and marijuana use often continues among patients diagnosed with human papillomavirus-negative oropharyngeal cancer, a finding that leads this roundup of news from studies reported this week. (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - February 14, 2014 Category: Surgery Source Type: news
OncoBriefs: H&N Cancer, Melanoma, Disparities
(MedPage Today) -- Drinking and marijuana use often continues among patients diagnosed with human papillomavirus-negative oropharyngeal cancer, a finding that leads this roundup of news from studies reported this week. (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - February 14, 2014 Category: American Health Source Type: news
Study: Oropharyngeal cancer on the rise in young adults
(Henry Ford Health System) A new study reveals an alarming increase in oropharyngeal cancers among young adults. While the exact cause for this phenomenon is unknown, the human papillomavirus may be to blame. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 29, 2014 Category: Infectious Diseases Source Type: news
Surgery 'better than chemotherapy' for tongue cancer
For the treatment of cancer, many would consider chemotherapy to be the best option. But for tongue cancer, new research suggests that surgery may be the most effective primary port of call. This is according to a study published in the journal JAMA Otolaryngology Head and Neck Surgery.According to the American Cancer Society, approximately 36,000 people will have been diagnosed with oral cavity or oropharyngeal cancers, which includes tongue cancer, in the US throughout 2013. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 30, 2013 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
Advanced form of proton therapy reduces need for feeding tubes by 50 percent
A new study from researchers at The University of Texas MD Anderson Proton Therapy Center found that the use of feeding tubes in oropharyngeal carcinoma (OPC) cancer patients treated with intensity modulated proton therapy (IMPT) decreased by more than 50 percent compared to patients treated with intensity modulated radiation therapy (IMRT). This suggests that proton therapy may offer vital quality of life benefits for patients with tumors occurring at the back of the throat. The results, presented by the lead researcher, Steven J. Frank, M.D... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 29, 2013 Category: Consumer Health News Tags: Ear, Nose and Throat Source Type: news
Growing number of young adults with oropharyngeal cancer linked to HPV
The human papillomavirus (HPV) may be to blame for the alarming increase of young adults with oropharyngeal cancer, according to researchers from Henry Ford Hospital in Detroit. The study reveals an overall 60 percent increase from 1973 and 2009 in cancers of the base of tongue, tonsils, soft palate and pharynx in people younger than age 45. Among Caucasians, there was a 113 percent increase, while among African-Americans the rate of these cancers declined by 52 percent during that period of time... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 26, 2013 Category: Consumer Health News Tags: Ear, Nose and Throat Source Type: news
ASTRO: Proton therapy helps oropharyngeal patients
Oropharyngeal carcinoma patients treated with intensity-modulated proton therapy (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 26, 2013 Category: Radiology Source Type: news
HPV linked to growing number of young adults with oropharyngeal cancer
(Henry Ford Health System) The human papillomavirus may be to blame for the alarming increase of young adults with oropharyngeal cancer, according to researchers from Henry Ford Hospital in Detroit. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 24, 2013 Category: Global & Universal Source Type: news
